In this section, we introduce a few key effects that we believe modulate this relationship, using semaglutide 2.4 mg as a model for GLP-1 agonists
'THANK YOU TO THE HARDEST WORKING TEAM AROUND I AM FOREVER GRATEFUL THAT I GET TO WORK WITH THE BEST PEOPLE IN THE , THANK YOU @tameimpala FOR JOINING ME AND HELPING ME TICK OFF ANOTHER BUCKETLIST DREAM AND THANK YOU @glastofest @emily_eavis (brb about to go watch it all on iplayer!!!!)'
The bottom line for 2026 decision-making: if you researched GLP-1 telehealth programs in late 2025 and are returning to make a decision now, the options, availability, and regulatory context you were looking at then may not match what's currently on the table
When you use a Mounjaro or Zepbound pen, you are getting exactly 2.5, 5, 7.5, 10, 12.5, or 15 mg of tirzepatide